Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19. Rodriguez-Perez AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al. J Autoimmun 2021;122:102683.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rodriguez-Perez AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19. J Autoimmun 2021;122:102683.
PMID: 34144328